FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Biologics

Questions About Plausible Mechanism Pathway Continue: Attorneys

Three Ropes & Gray attorneys outline FDAs new plausible mechanism pathway for approving personalized therapies and discuss questions that remain about...

latest-news-card-1
Medical Devices

Baxter Recalls Life2000 Ventilators Over Cybersecurity Risks

Baxter recalls (Class 1) its Life2000 Ventilation System after the company discovered a cybersecurity vulnerability.

latest-news-card-1
Human Drugs

Novo Nordisk Seeks Approval for Higher-dose Wegovy

Novo Nordisk files a supplemental NDA seeking approval for a higher-dose version of weight-loss drug Wegovy (semaglutide).

latest-news-card-1
Human Drugs

Agency Reference Model Suggested for Next Level Preemption

A law journal article, discussed in Regulatory Review, proposes a framework courts could use to consider state challenges to federal preemption of dru...

latest-news-card-1
Medical Devices

3 Former Magellan Execs Sentenced

The Department of Justice says a Massachusetts federal judge sentenced three former Magellan Diagnostics executives for hiding a malfunction in the co...

latest-news-card-1
Human Drugs

Quality System Violations at Hong Qiangxing Electronics

FDA warns Chinas Hong Qiangxing Shenzhen Electronics about Quality System violations in its production of several medical devices.

latest-news-card-1
Human Drugs

Owen Biosciences CGMP Violations

FDA warns Baton Rouge, LA-based Owen Biosciences about CGMP violations in its production of finished drugs as a contract manufacturing facility.

latest-news-card-1
Biologics

Gene Therapy for Broader Spinal Muscular Atrophy Range

FDA approves Novartis Itvisma (onasemnogene abeparvovec-brve), a new formulation of a gene therapy for a broader age of spinal muscular atrophy patien...

latest-news-card-1

Guidance on Where to Submit Cross-Center Master Files

FDA issues a draft guidance with recommendations to help master file holders determine to which Center to submit cross-Center master files.

latest-news-card-1

Makary Missing the Point on Advisory Committees: Zuckerman

National Center for Health Research president Diana Zuckerman defends FDA advisory committees, saying they do a more thorough job of evaluating produc...